foundation medicine genomic testing laboratory
Foundation Medicine Campus

A Culture Dedicated to Advancing Cancer Care

Foundation Medicine Inc.

Our work offers more than information; it can inspire hope in patients, families, friends, physicians, and caregivers.

Through constant innovation, we can make breakthroughs to help achieve improved outcomes for more individuals living with cancer. That’s why we foster a collaborative culture that motivates us to do our best work and be a partner in every patient's journey.

Our approach combines genomic profile products and data services to generate insights that may help doctors match patients to more treatment options and help accelerate the development of new therapies.

FOUNDATION FACTS

Foundation Medicine Support of the Clinical and Research Community

  • >150k1-3

    Patients Profiled

  • >30

    Biopharma Partners

  • >2504

    Published Manuscripts

  1. Foundation Medicine 2017 First Quarter Results and Recent Highlights. Available at: http://investors.foundationmedicine.com/releasedetail.cfm?releaseid=1025603 (Accessed December 2017).
  2. Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights. Available at: http://investors.foundationmedicine.com/releasedetail.cfm?ReleaseID=1035418 (Accessed December 2017).
  3. Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights. Available at: http://investors.foundationmedicine.com/releasedetail.cfm?ReleaseID=1046571 (Accessed December 2017).
  4. A search for “Foundation Medicine”[Affiliation] on the NCBI database resulted in over 270 publications, as of December 2017. Available at: https://www.ncbi.nlm.nih. govpubmed/?term=“Foundation+Medicine%22%5BAffiliation%5D (Accessed December 2017).

Contact Us

|

Hoffmann-La Roche Limited
7070 Mississauga Road
Mississauga, ON L5N 5M8 Canada

For customer service inquiries about ordering Foundation Medicine testing, please contact FoundationNavigate at:

EMAIL
[email protected]

PHONE
1-888-650-4835

This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding a Roche product, please email [email protected] or call 1-888-762-4388. You can also report adverse events relating to any product to Health Canada directly by going to the Canada Vigilance Program website at https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html.

FoundationOne®CDx, FoundationOne®Heme and FoundationOne®Liquid CDx are next-generation sequencing services performed by Foundation Medicine, Inc. at laboratories located in Cambridge, Massachusetts, USA. Hoffmann-La Roche Limited markets these services in Canada under an exclusive license from Foundation Medicine, Inc. The FoundationOne®CDx, FoundationOne®Heme and FoundationOne®Liquid CDx reports are prepared exclusively by Foundation Medicine, Inc., without Hoffmann-La Roche Limited’s involvement. The reports may include scientific information about experimental medicinal product(s) or uses that are not approved and/or available in Canada. Hoffmann-La Roche Limited does not endorse or recommend the unapproved use of any medicinal product. FoundationOne® and FoundationOne®CDx are registered trade-marks of Foundation Medicine, Inc., used under license.

Privacy Policy | Terms of Use | Cookie Preferences
© 2024 Hoffmann-La Roche Limited

This website contains information intended for a Canadian audience only, and may contain information or treatment options that are not valid or accessible in other countries. We are not responsible for the access or use outside of Canada of any information on this website which may not comply with laws and regulations applicable outside of Canada.

This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding a Roche product, please email [email protected] or call 1-888-762-4388. You can also report adverse events relating to any product to Health Canada directly by going to the Canada Vigilance Program website at https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html.